The triglyceride-glucose–waist-to-height ratio is the strongest predictor of reduced kidney function in elderly hypertensive patients

• by Jiaying Ling, Shu Xie, Yanyan Zhang, Danxiang Chen, Changwei Lü, Gongcheng Wang, Xueqin Li

• June 15, 2026

Recombinant human IGF-1 alleviates dyslipidemia induced by lactational maternal dietary restriction

• by Xin Liu, Yuanyuan Ma, Hong Cui, Qi Feng

• June 4, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.

• by Kathryn Wighton

• June 5, 2026

• 4 min